Home PerkinElmer Inc.

PerkinElmer Inc.

PerkinElmer Launches Pre-eclampsia Kit for Enhanced Management

This kit will enable short term prediction of pre-eclampsia and aid in diagnosis in the second and third trimesters of pregnancy together with the previously launched DELFIA® Xpress PlGF 1-2-3™ assay.

PG-Seq™ Rapid Non-Invasive Preimplantation Genetic Testing Kit as Alternative to IVF Embryo Biopsies

The new kit shown to achieve over 90% correlation rate between biopsied embryos and testing spent culture media.

Clinical Study Published in Prenatal Diagnosis Further Validates Vanadis®

The study demonstrated that cfDNA testing with the highly automated Vanadis NIPT system does not require specialized personnel for screening. The Vanadis system is also designed to help reduce cost and allow wider population-based screening.

PerkinElmer Completes Sale of Medical Imaging Business to Varex Imaging

PerkinElmer, Inc. is a global leader focused on innovating for a healthier world. The Company reported revenue of approximately $2.1 billion in 2016, has about 9,000 employees serving customers in more than 150 countries, and is a component of the S&P 500 Index.